Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.62 |
| ▸ | SELP | P16109 | 1/20 | 0.62 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ERN1 | O75460 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | CHUK | O15111 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30211643 | 0.89 | ERN1 (0.54) | SELLSELPHDAC1KDM4EALDH1A1 | |
| SCHEMBL3424158 | 0.89 | ERN1 (0.54) | SELLSELPHDAC1KDM4EALDH1A1 | |
| SCHEMBL424097 | 0.83 | KDM4E (0.67) | SELLSELPKDM4EALDH1A1MAPT | |
| SCHEMBL29552052 | 0.83 | KDM4E (0.67) | SELLSELPKDM4EALDH1A1MAPT | |
| SCHEMBL8548472 | 0.81 | KDM4E (0.46) | SELLSELPHDAC1KDM4EALDH1A1 | |
| SCHEMBL10550107 | 0.81 | KDM4E (0.46) | SELLSELPHDAC1KDM4EALDH1A1 | |
| SCHEMBL30366773 | 0.81 | KDM4E (0.46) | SELLSELPHDAC1KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL9377889 | 0.81 | KDM4E (0.64) | SELLSELPKDM4EALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL8664317 | 0.81 | KDM4E (0.64) | SELLSELPKDM4EALDH1A1MAPT | |
| SCHEMBL11054445 | 0.80 | SELL (0.62) | SELLSELPKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022235-A1 | DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-01-26 | — | — | US | claimed |
| EP-4061351-A1 | DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORS | The Regents of the University of California (US) | 2022-09-28 | — | — | EP | claimed |
| CN-114727975-A | Antiandrogen receptor/AKR 1C3 inhibitors | 加利福尼亚大学董事会 | 2022-07-08 | — | — | CN | claimed |
| WO-2021101903-A1 | DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-05-27 | — | — | WO | claimed |
| EP-0610444-B1 | Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases | ELFORD HOWARD L (US) | 2003-01-29 | — | — | EP | claimed |
| EP-0900781-B1 | Phenolic acid amides of hydroxy substituted benzylamines | HAARMANN & REIMER GMBH (DE) | 2002-03-20 | — | — | EP | claimed |
| EP-4711432-A1 | ADHESIVE TAPE, CHEMICAL SOLUTION TANK, AND METHOD FOR PRODUCING CHEMICAL SOLUTION TANK | Sekisui Chemical Co., Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-12564630-B2 | Vaccine adjuvants | VIROVAX LLC (US) | 2026-03-03 | — | — | US | disclosed |
| WO-2025079595-A1 | ADHESIVE SHEET, LAMINATED SHEET, CHEMICAL LIQUID TANK, AND METHOD FOR MANUFACTURING CHEMICAL LIQUID TANK | 積水化学工業株式会社 | 2025-04-17 | — | — | WO | disclosed |
| CN-119799806-A | Preparation process for efficiently producing gallic acid | 广州卫生职业技术学院 | 2025-04-11 | — | — | CN | disclosed |
| WO-2024232419-A1 | ADHESIVE SHEET, MULTILAYER SHEET, CHEMICAL LIQUID TANK, AND METHOD FOR PRODUCING CHEMICAL LIQUID TANK | 積水化学工業株式会社 | 2024-11-14 | — | — | WO | disclosed |
| WO-2024232418-A1 | ADHESIVE TAPE | 積水化学工業株式会社 | 2024-11-14 | — | — | WO | disclosed |
| WO-2024232420-A1 | ADHESIVE TAPE, CHEMICAL SOLUTION TANK, AND METHOD FOR PRODUCING CHEMICAL SOLUTION TANK | 積水化学工業株式会社 | 2024-11-14 | — | — | WO | disclosed |
| US-4623659-A | RIBONUCLEOTIDE REDUCTASE INHIBITORS | RIET BARTHOLOMEUS VAN T (US) | 1986-11-18 | — | — | US | disclosed |
| EP-0144396-A4 | POLYHYDROXYBENZOIC ACID DERIVATIVES. | RIET BARTHOLOMEUS VAN T (US) | 1986-08-21 | — | — | EP | disclosed |
| EP-0144396-A1 | POLYHYDROXYBENZOIC ACID DERIVATIVES. | RIET BARTHOLOMEUS VAN T (US) | 1985-06-19 | — | — | EP | disclosed |
| WO-1984004676-A1 | POLYHYDROXYBENZOIC ACID DERIVATIVES | RIET BARTHOLOMEUS VAN T | 1984-12-06 | — | — | WO | disclosed |
| US-4448730-A | ANTITUMOR AGENTS | RIET BARTHOLOMEUS VAN T | 1984-05-15 | — | — | US | disclosed |
| US-4394389-A | ANTITUMOR AGENTS | RIET BARTHOLOMEUS VAN T | 1983-07-19 | — | — | US | disclosed |
| US-4263322-A | RIBONUCLEOTIDE REDUCTASE INHIBITORS | RIET BARTHOLOMEUS VAN T | 1981-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022235-A1 | DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORS | AKR1C3, AR, AKR1C4 | SELL 4852/4885SELP 4778/4885HDAC1 203/4885 |
| US-12564630-B2 | Vaccine adjuvants | TLR7, TLR8, TLR3 | SELL 3032/4885SELP 2608/4885HDAC1 3192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.